Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI).
Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI).
复制标题
DOI:
10.1002/acr.20544
复制
发表时间:
2011-11
影响因子:
4.7
通讯作者:
Omachi, Theodore A.
中科院分区:
文献类型:
--
作者:
Omachi, Theodore A.
Fatigue is a major symptom associated with rheumatologic diseases such as systemic lupus erythematosis and rheumatoid arthritis and may be a direct manifestation of disease activity, but such fatigue may also be related to sleep disturbances (1, 2). Indeed, sleep disturbances are common in a variety of rheumatologic diseases (3–5). Such disturbed sleep may be due to pain, depression, lack of exercise, or corticosteroid usage (6–8). Sleep quality may also be impaired by comorbid sleep disorders, such as obstructive sleep apnea or restless leg syndrome, the prevalences of which are reported to be high in rheumatologic populations (9–12). Sleep disturbances may, in turn, impact functional disability, lower pain thresholds, or impair immune function and thus contribute to rheumatologic-associated morbidities (13–15). Sleep disturbances in fibromyalgia and rheumatoid arthritis have received relatively more attention than in other rheumatologic diseases, but even in fibromyalgia and rheumatoid arthritis, there are many unanswered questions related to the causes and outcomes of sleep disturbances (3).The study of sleep disturbances can be onerous because gold standard direct tests, such as polysomnography and multiple sleep latency testing, are both expensive and require considerable commitment of time from research subjects. Laboratory-based sleep studies may present an additional challenge in rheumatologic populations in whom mobility restriction and pain may significantly increase subject burden. Thus, there is strong impetus for utilizing patient-reported measures in assessing sleep and sleep-related outcomes in rheumatologic diseases.
登录
查看更多内容
影响因子:
4.7
作者:
Carpenter, JS;Andrykowski, MA
通讯作者:
Andrykowski, MA
影响因子:
5.6
作者:
Chasens, Eileen R.;Ratcliffe, Sarah J.;Weaver, Terri E.
通讯作者:
Weaver, Terri E.
影响因子:
45.3
作者:
Berger, Ann M.;Kuhn, Brett R.;Agrawal, Sangeeta
通讯作者:
Agrawal, Sangeeta
影响因子:
4.7
作者:
Backhaus, J;Junghanns, K;Hohagen, F
通讯作者:
Hohagen, F
影响因子:
4.8
作者:
Bastien, Celyne H.;Vallieres, Annie;Morin, Charles M.
通讯作者:
Morin, Charles M.